Related Experiment Video
Updated: Jul 3, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
Steering Protein Generative Models at Test-Time for Guided AAV2 Capsid Design
Ben Viggiano1, Wenhui Sophia Lu2, Xiaowei Zhang3
1Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
None:
Recent advances in protein generative models have created new opportunities for protein engineering. However, a significant challenge remains in effectively steering these models to generate sequences with specific, desired functionalities, especially when these properties are defined by "black-box" or non-differentiable fitness functions. To address this, we present ProVADA+, a model-agnostic framework that guides pretrained generative models at testtime without costly retraining. Our approach introduces a reinforcement learning-based adaptive masking technique (MADA-DUCB) that significantly accelerates convergence. We demonstrate this framework on the challenging task of designing novel Adeno-Associated Virus 2 (AAV2) capsids. By coupling a ProteinMPNN generative prior with a fine-tuned AAV viability oracle, our method successfully navigates the rugged fitness landscape where unguided random mutagenesis is ineffective-with prior experiments showing as few as 0.3% of variants with six or more mutations are viable. In its final iterations, ProVADA generated a pool of novel candidates with a mean viral selection score of 2.72, consistently scoring highly viable variants while maintaining a diverse range of sequence similarity to the wildtype sequence. Our results show that ProVADA provides a powerful and efficient framework for accelerating the design of proteins with complex, user-defined properties.
More Related Videos
09:21Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
Published on: January 29, 2019
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022
Related Concept Videos
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.